Literature DB >> 2219284

Multiple site estimates of erythropoietin and renin in polycythemic kidney transplant patients.

J M Aeberhard1, P A Schneider, M B Vallotton, A Kurtz, M Leski.   

Abstract

The development of polycythemia after renal transplantation is a well known phenomenon and its etiology remains controversial. In particular, it is unknown whether inappropriate erythropoietin (EPO) production could be a reason. Utilizing a sensitive radioimmunoassay for EPO we have measured EPO concentrations in venous blood from native and grafted kidneys in three normocythemic and seven polycythemic patients. We found that (1) in our posttransplantation polycythemic patients there are inappropriately high systemic EPO levels, hence that posttransplantation polycythemia is related to EPO overproduction. (2) This high EPO production comes from the native kidneys. (3) There is a correlation between EPO and renin levels in the peripheral as well as in native and transplanted kidneys' venous samples.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2219284     DOI: 10.1097/00007890-199010000-00017

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  6 in total

Review 1.  Hypertension after renal transplantation.

Authors:  V Schwenger; M Zeier; E Ritz
Journal:  Curr Hypertens Rep       Date:  2001-10       Impact factor: 5.369

2.  Secondary polycythaemia associated with bilateral renal lymphocoeles.

Authors:  I E Burton; P Sambrook; L J McWilliam
Journal:  Postgrad Med J       Date:  1994-07       Impact factor: 2.401

3.  Efficacy of enalapril after ineffective theophylline treatment on erythrocytosis after renal transplantation.

Authors:  T Yagisawa; H Toma; H Yaguchi; M Tomaru; Y Iijima; H Suzuki; T Nakada
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

4.  Increased erythropoietin response to venesection in erythrocytosic renal transplant patients.

Authors:  O Oymak; H Demiroğlu; T Akpolat; Y Erdem; U Yasavul; C Turgan; S Cağlar; S Dündar; S Kirazli
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

Review 5.  HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond.

Authors:  Patrick H Maxwell; Kai-Uwe Eckardt
Journal:  Nat Rev Nephrol       Date:  2015-12-14       Impact factor: 28.314

Review 6.  Hypertension after renal transplant.

Authors:  Fasika Tedla; Rick Hayashi; Samy I McFarlane; Moro O Salifu
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-07       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.